0001104659-22-096653.txt : 20220831 0001104659-22-096653.hdr.sgml : 20220831 20220831201411 ACCESSION NUMBER: 0001104659-22-096653 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220829 FILED AS OF DATE: 20220831 DATE AS OF CHANGE: 20220831 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Hagopian Henry III CENTRAL INDEX KEY: 0001821822 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39202 FILM NUMBER: 221219276 MAIL ADDRESS: STREET 1: C/O ORGANOGENESIS INC., 85 DAN ROAD CITY: CANTON STATE: MA ZIP: 02021 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Annovis Bio, Inc. CENTRAL INDEX KEY: 0001477845 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 262540421 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1055 WESTLAKES DRIVE, SUITE 300 CITY: BERWYN STATE: PA ZIP: 19312 BUSINESS PHONE: 610-727-3913 MAIL ADDRESS: STREET 1: 1055 WESTLAKES DRIVE, SUITE 300 CITY: BERWYN STATE: PA ZIP: 19312 FORMER COMPANY: FORMER CONFORMED NAME: QR Pharma, Inc. DATE OF NAME CHANGE: 20091202 4 1 tm2224852-2_4seq1.xml OWNERSHIP DOCUMENT X0306 4 2022-08-29 0 0001477845 Annovis Bio, Inc. ANVS 0001821822 Hagopian Henry III C/O ANNOVIS BIO, INC. 1055 WESTLAKES DRIVE, SUITE 300 BERWYN PA 19312 0 1 0 0 Chief Financial Officer Stock Option (right to buy) 11.55 2022-08-29 4 A 0 120000 0 A 2032-08-29 Common Stock 120000 120000 D The stock option vests one-third on August 29, 2023 and the remaining two-thirds will vest in eight consecutive quarterly installments beginning the fifteenth month after August 29, 2022, and will vest in full upon a Change of Control (as defined in the Company's 2019 Equity Incentive Plan), with vesting conditioned on continued employment on the applicable vesting dates. /s/ Henry Hagopian, III 2022-08-31